Hearing loss risk after childhood cancer
Part of Cancer, Ear, nose & throat, Injuries & trauma clinical trials.
This study looks at why some people who survived cancer as children or young adults develop hearing loss. It will check their hearing and review their past cancer treatments to find risk factors, so that future patients can be monitored more closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for cancer when you were younger than 25, such as a brain tumor, lymphoma, leukemia, or other solid tumor.
- You are between 18 and 50 years old at the time of hearing tests.
- You have been cancer-free for at least 5 years.
- You are part of the FCCSS survivor group or are being followed at a long-term follow-up clinic at Curie Institute or Gustave Roussy.
- You have health insurance and can sign a consent form.
- You are able to provide details about your past cancer treatments, like chemotherapy doses and radiation fields.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
This study compares how patients’ quality of life changes when people who have hearing loss from platinum chemotherapy use a hearing aid versus not using one. It may help understand whether hearing aids improve daily life during treatment.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares patients who get cisplatin with those who only get radiation, to understand and possibly reduce these side effects.
This study looks at how tinnitus (ringing in the ears) and hearing problems may develop after radiotherapy alone or with certain chemotherapy for high-risk head and neck cancer. The goal is to better understand who is more likely to experience these side effects.
This study looks at how common cancer treatments (certain chemotherapies and radiation to the head and neck) affect hearing in noisy places, thinking skills, and quality of life related to hearing. It aims to understand and possibly reduce these side effects.
Hear when a new Ototoxicity, Drug-Induced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.